New blood tests aim to unlock mysteries of rare inflammatory diseases
NCT ID NCT06971289
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study aims to better understand rare autoinflammatory diseases by developing blood tests that measure inflammation markers. Researchers will analyze blood samples from 60 adults and children with these conditions. The goal is to identify specific inflammation pathways, which could improve diagnosis and knowledge of these diseases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better understanding and diagnosis of rare autoinflammatory diseases.
- What could go wrong
- This is an early-stage observational study, not a treatment trial. It may not directly benefit participants or lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOINFLAMMATORY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genetic hunt for hidden causes of mysterious inflammatory diseases
- Coaching eases tough move to adult rheumatology care
- New blood tests could help monitor Flare-Ups in kids with arthritis
- Scientists hunt for genetic clues in rare childhood immune disorders
- NIH launches major study to unlock secrets of rare inflammatory diseases
- Scientists investigate mysterious genetic variants behind rare inflammatory diseases